Abstract

LIGHT recruits and activates naive T cells in the islets at the onset of diabetes. IFN‐γ secreted by activated T lymphocytes is involved in beta cell apoptosis. However, whether LIGHT sensitizes IFNγ‐induced beta cells destruction remains unclear. In this study, we used the murine beta cell line MIN6 and primary islet cells as models for investigating the underlying cellular mechanisms involved in LIGHT/IFNγ – induced pancreatic beta cell destruction. LIGHT and IFN‐γ synergistically reduced MIN6 and primary islet cells viability; decreased cell viability was due to apoptosis, as demonstrated by a significant increase in Annexin V+ cell percentage, detected by flow cytometry. In addition to marked increases in cytochrome c release and NF‐κB activation, the combination of LIGHT and IFN‐γ caused an obvious decrease in expression of the anti‐apoptotic proteins Bcl‐2 and Bcl‐xL, but an increase in expression of the pro‐apoptotic proteins Bak and Bax in MIN6 cells. Accordingly, LIGHT deficiency led to a decrease in NF‐κB activation and Bak expression, and peri‐insulitis in non‐obese diabetes mice. Inhibition of NF‐κB activation with the specific NF‐κB inhibitor, PDTC (pyrrolidine dithiocarbamate), reversed Bcl‐xL down‐regulation and Bax up‐regulation, and led to a significant increase in LIGHT‐ and IFN‐γ‐treated cell viability. Moreover, cleaved caspase‐9, ‐3, and PARP (poly (ADP‐ribose) polymerase) were observed after LIGHT and IFN‐γ treatment. Pretreatment with caspase inhibitors remarkably attenuated LIGHT‐ and IFNγ‐induced cell apoptosis. Taken together, our results indicate that LIGHT signalling pathway combined with IFN‐γ induces beta cells apoptosis via an NF‐κB/Bcl2‐dependent mitochondrial pathway.

Highlights

  • Type 1 diabetes mellitus (T1DM) is an organ-specific autoimmune disorder characterized by chronic inflammation and pancreatic insulinproducing beta cell destruction

  • LIGHT [lymphotoxin (LT)-like, exhibits inducible expression and competes with HSV glycoprotein D for herpesvirus entry mediator (HVEM), a receptor expressed by T lymphocytes], known as TNFSF14, is a new member of the tumour necrosis factor (TNF) superfamily and plays an important role during innate or adaptive immune processes via binding to its receptors, lymphotoxin b receptor (LTbR) or HVEM [8,9,10,11]

  • To explore the effect of LIGHT and IFN-c combination on pancreatic beta cell destruction, cells were exposed to increasing concentrations of LIGHT in the presence of IFN-c for 48 h

Read more

Summary

Introduction

Type 1 diabetes mellitus (T1DM) is an organ-specific autoimmune disorder characterized by chronic inflammation and pancreatic insulinproducing beta cell destruction. One of the main factors leading to beta cell apoptosis is the secretion of the pro-inflammatory cytokine, interferon (IFN)-c, by autoreactive T lymphocytes and macrophages invading the islets. Beta cell apoptosis is driven by specific combinations of cytokines, such as the combination of IFN-c and tumour necrosis factor (TNF)-a, but not by a single cytokine alone [4, 5]. The combination and distribution of LIGHT [lymphotoxin (LT)-like, exhibits inducible expression and competes with HSV glycoprotein D for herpesvirus entry mediator (HVEM), a receptor expressed by T lymphocytes], known as TNFSF14 (tumour necrosis factor superfamily member 14), is a new member of the TNF superfamily and plays an important role during innate or adaptive immune processes via binding to its receptors, lymphotoxin b receptor (LTbR) or HVEM [8,9,10,11]. Treatment with LTbR-Ig in non-obese diabetic (NOD) mice prevents insulitis and insulin-dependent diabetes mellitus, and LTbR-Ig treatment at a late stage of insulitis a 2016 The Authors

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call